53902-17-3

Basic information

• Product Name: TRANILAST
• Synonyms: SB-252218;N-(3',4'-DIMETHOXYCINNAMOYL)ANTHRANILIC ACID;2-[3-(3,4-Dimethoxy-phenyl)-acryloylamino]-benzoic acid;2-[[3-(3-Methoxy-4-propoxyphenyl)-1-oxo-2-propen-1-yl]amino]benzoic acid
• CAS NO: 53902-17-3
• Molecular Formula: C18H17NO5
• Molecular Weight: 327.33
• Mol File: 53902-17-3.mol
• Article Data: 0

Chemical Properties

• Melting Point: 166.2-168.2 °C(lit.)
• Boiling Point: 596.8±50.0 °C(Predicted)
• Appearance: /
• Density: 1.247±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• Solubility: DMSO: 18 mg/mL
• PKA: 3.47±0.36(Predicted)
• CAS DataBase Reference: TRANILAST(CAS DataBase Reference)
• NIST Chemistry Reference: TRANILAST(53902-17-3)
• EPA Substance Registry System: TRANILAST(53902-17-3)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Safety Statements: 26-36
• WGK Germany: 3
• RTECS: DG8731000
• Hazardous Substances Data: 53902-17-3(Hazardous Substances Data)

Usage

General Description

Tranilast is a chemical compound that has been used in the treatment of various conditions such as asthma, atopic dermatitis, and hypertrophic scars. It is a potent anti-inflammatory and anti-allergic agent that works by inhibiting the release of inflammatory substances and reducing the production of collagen. Tranilast also has anti-fibrotic properties, which make it effective in preventing the formation of scar tissue. It has been shown to be well-tolerated and safe for long-term use, making it a promising option for the management of chronic inflammatory and fibrotic conditions. Furthermore, Tranilast has also been investigated for its potential use in treating conditions such as diabetic nephropathy, glomerulosclerosis, and various types of cancer.